Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A biomarker, or biological marker, is a general term for a measurable indicator of a biological state or condition. It is defined by the NIH and FDA as a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacologic responses to a therapeutic intervention (NIH/FDA BEST Resource, 2016). Biomarkers can encompass a wide array of entities, including specific proteins, genetic mutations, metabolites, or physiological measurements such as blood pressure or heart rate. They are essential in modern medicine for diagnosing diseases, predicting disease progression, and identifying patients most likely to respond to specific therapies (Strimbu & Tavel, 2010). Because the term 'Biomarker' describes a broad class of indicators rather than a specific protein, receptor, or enzyme, it is not considered a therapeutic target in itself. Instead, it serves as a fundamental concept in clinical research and drug development to evaluate the interaction between a drug and its intended molecular target.
Not applicable as this is a broad category of clinical/biological indicators and not a specific molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Biomarker.